Since the recognition 30 years ago that surgery on children with posterior fossa tumors can result in postoperative mutism, the features surrounding this behavioral and functional "syndrome" have gained much attention, but sadly, disproportionately less elucidation. The clinical spectrum is varied and one needs to look no further than the skillful description provided 20 years prior by Dr. Robin Humphreys to identify the afflicted child. The child awoke immediately after operation and conversed appropriately. The next day he became increasingly irritable and refused to talk. He layed curled on his side, followed commands, refused to open his eyes. At 6 weeks postoperative he was alert, understood most conversation but did not engage in verbal speech. By 4 months he was able to verbalize with only 'yes','no' and 'hi'. By 6 months he was capable of carrying on a conversation.
The reported incidence varies widely, but in this most recent publication by a highly skilled team of neurooncology specialists, the incidence of posterior fossa syndrome (PFS) reaches nearly 40%. 5 Perplexing is why the frequency of PFS continues to increase during an era in which we have witnessed substantial reductions in overall surgical morbidity. The most likely explanation for this divergence is the expanding definitional criteria and wider recognition of this neurological and neurobehavioral syndrome. Although one may be tempted to challenge this most recent report as inflating the true incidence of PFS due to more relaxed inclusion criterion, the experience of this highly regarded group should serve as cautionary note: removing tumors from the cerebellum in developing children is far from risk free.
What has not yet come to light is how one predicts which patients are at risk for developing PFS and how to prevent this phenomenon. This current report correlates MR-based cerebellar atrophy at 1 year after surgery with PFS. Review of an MR image 1 year after surgery contributes little help regarding prevention. From the surgeon's perspective, avoiding the syndrome is problematic. What is currently known is that surgical intervention for tumors that infiltrate the vermis, brainstem, deep cerebellar nuclei, cerebellar outflow tracts, or some combination of these structures is contributory. Because the median and paramedian cerebellum have been repeatedly cited as related to PFS, alternative surgical trajectories have been advocated, most notably the telovelar or cerebellomedullary fissure approach. As Dr. Wells and coauthors 5 note, this surgical approach does not fully protect the patient from PFS nor has the approach been systemically compared with a transvermian approach. Further, because most medulloblastomas arise in the cerebellar midline some vermian injury is likely, if not through the approach than via the tumor resection. Some reduced risk may come with further clarification of the anatomical milieu of posterior fossa brain tumors just as neurosurgeons and neuroradiologists have done with supratentorial tumors. 3 Another option to be considered in PFS avoidance is to limit tumor resection in an effort to bypass injury of adjoining tissue. In this scenario one could envision using a tailored surgical approach (such as limited removal) in high-risk patients. This would be a legitimate option if those patients deemed to be at substantial risk could be readily identified and if subtotal tumor removal did not compromise their outcome. As stated by the authors in this current report 5 and substantiated by most other published works, risk criteria for PFS defined on preoperative MR imaging have yet to be clarified. Additionally, repeated prospective cooperative group studies have supported the fact that significant residual tumor is a negative prognostic indicator. 1, 6 Thus, limited tumor removal does not currently appear to be a justifiable option unless the tumor is known to invade the brainstem and cerebellar peduncles.
The authors of this report suggest that some intraoperative adjuncts may contribute to reducing the incidence of PFS. Electrophysiological monitoring appears unlikely to affect the postoperative incidence of this syndrome because the exact anatomical basis remains elusive and no appreciable method exists for monitoring the dentatorubo-thalamic tracts. Additionally, the avoidance of the Cavitron ultrasonic aspirator or self-retaining retractors remains only conjectural and anecdotal at present.
Another point worthy of consideration is whether a preventive mechanism is crucial. Tumor removal in other anatomical regions (such as the supplementary motor cortex and ventricular trigone) is associated with predictable neurological morbidity. In these situations the expected injuries are considered acceptable in the name of achieving a cure, a sentiment that is, in part, due to variable rates of recovery. Should we similarly accept that the risk of PFS as an unavoidable byproduct of medulloblastoma removal? Although we can be confident that the majority of these children will return to a baseline level of func-tion, the authors in this report and the recent Children's Oncology Group study have shown that a subset of children will not fully recover from their injury. 4 Admittedly, continued efforts need to be made to lessen the incidence of PFS, but an expectation of risk-free surgery for removal of posterior fossa brain tumors is not realistic.
Regrettably, PFS may not be entirely avoidable. However, some basic tenets should be employed as an effort to do so. First, the emotional impact can be lessened with a detailed informed consent process with the parents. Second, the use of perioperative steroids and minimal retraction can lessen edema surrounding the resection cavity. Third, anatomical preservation is an absolute must at the level of the brain stem and cerebellar peduncles. Fourth, if a vermian corticectomy is used, the degree should be minimized.
In closing, I would agree with the authors that more "research is needed to better characterize the underlying mechanism" for PFS. Until then, the neurosurgeon will continue to try and balance the scales between aggressive tumor removal from an oncological perspective with minimal tissue injury from a neurobehavioral consideration using somewhat nebulous guidance.
